Form 8-K - Current report:
SEC Accession No. 0001070081-20-000108
Filing Date
2020-06-10
Accepted
2020-06-10 16:24:21
Documents
14
Period of Report
2020-06-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k61020.htm   iXBRL 8-K 51138
  Complete submission text file 0001070081-20-000108.txt   194762

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20200610.xsd EX-101.SCH 4701
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20200610_cal.xml EX-101.CAL 640
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20200610_def.xml EX-101.DEF 1490
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20200610_lab.xml EX-101.LAB 26468
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20200610_pre.xml EX-101.PRE 13685
9 EXTRACTED XBRL INSTANCE DOCUMENT a8k61020_htm.xml XML 4249
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 20954926
SIC: 2834 Pharmaceutical Preparations